La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Dopamine Agonists (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine Agonists (administration & dosage) < Dopamine Agonists (adverse effects) < Dopamine Agonists (blood)  Facettes :

List of bibliographic references indexed by Dopamine Agonists (adverse effects)

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000647 (2015) A. Antonini [Italie] ; L. Bauer [Allemagne] ; E. Dohin [France] ; W H Oertel [Allemagne] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; M. Schmid [Allemagne] ; P. Singh [Allemagne] ; E. Tolosa [Espagne] ; K Ray Chaudhuri [Royaume-Uni]Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
000805 (2014) M. Rambour [France] ; C. Moreau [France] ; J. Salleron [France] ; D. Devos [France] ; A. Kreisler [France] ; E. Mutez [France] ; C. Simonin [France] ; A. Annic [France] ; K. Dujardin [France] ; A. Destée [France] ; L. Defebvre [France][Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
000855 (2014) Santiago Perez-Lloret [France] ; María Ver Nica Rey ; James Crispo ; Daniel Krewski ; Marise Lapeyre-Mestre ; Jean-Louis Montastruc ; Olivier RascolRisk of heart failure following treatment with dopamine agonists in Parkinson's disease patients.
000909 (2014) Thomas Cautres [France] ; Michel Cautres [France] ; Dania Mohty [France]Multiple valvular regurgitation associated with bromocriptine therapy.
000C49 (2013) Anna Castrioto [France] ; Andrea Kistner ; Hélène Klinger ; Eugénie Lhommée ; Emmanuelle Schmitt ; Valérie Fraix ; Stephan Chabardès ; Patrick Mertens ; Jean-Louis Quesada ; Emmanuel Broussolle ; Pierre Pollak ; Stéphane C. Thobois ; Paul KrackPsychostimulant effect of levodopa: reversing sensitisation is possible.
000C80 (2013) W M M. Schuepbach [France] ; J. Rau ; K. Knudsen ; J. Volkmann ; P. Krack ; L. Timmermann ; T D H Lbig ; H. Hesekamp ; S M Navarro ; N. Meier ; D. Falk ; M. Mehdorn ; S. Paschen ; M. Maarouf ; M T Barbe ; G R Fink ; A. Kupsch ; D. Gruber ; G-H Schneider ; E. Seigneuret ; A. Kistner ; P. Chaynes ; F. Ory-Magne ; C. Brefel Courbon ; J. Vesper ; A. Schnitzler ; L. Wojtecki ; J-L Houeto ; B. Bataille ; D. Maltête ; P. Damier ; S. Raoul ; F. Sixel-Doering ; D. Hellwig ; A. Gharabaghi ; R. Krüger ; M O Pinsker ; F. Amtage ; J-M Régis ; T. Witjas ; S. Thobois ; P. Mertens ; M. Kloss ; A. Hartmann ; W H Oertel ; B. Post ; H. Speelman ; Yves Agid [France] ; C. Schade-Brittinger ; G. DeuschlNeurostimulation for Parkinson's disease with early motor complications.
000E34 (2013) Santiago Perez-Lloret [Argentine] ; María Ver Nica Rey ; Pietro Lucca Ratti ; Olivier RascolRotigotine transdermal patch for the treatment of Parkinson’s Disease
001045 (2012) N. Carrière [France] ; A. Kreisler ; K. Dujardin ; A. Destée ; L. Defebvre[Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
001723 (2011) O. Rascol [France]Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release
001A44 (2010) Santiago Perez-Lloret [France] ; Olivier RascolDopamine receptor agonists for the treatment of early or advanced Parkinson's disease.
001A94 (2010) Stphane Thobois [France] ; Claire Ardouin [France] ; Eugnie Lhomme [France] ; Hlne Klinger [France] ; Christelle Lagrange [France] ; Jing Xie [France] ; Valrie Fraix [France] ; Maria Clara Coelho Braga [France] ; Rachid Hassani [France, Maroc] ; Andrea Kistner [France] ; Alexandra Juphard [France] ; Eric Seigneuret [France] ; Stephan Chabardes [France] ; Patrick Mertens [France] ; Gustavo Polo [France] ; Anthonin Reilhac [France] ; Nicolas Costes [France] ; Didier Lebars [France] ; Marc Savasta [France] ; Lon Tremblay [France] ; Jean-Louis Quesada [France] ; Jean-Luc Bosson [France] ; Alim-Louis Benabid [France] ; Emmanuel Broussolle [France] ; Pierre Pollak [France] ; Paul Krack [France]Non-motor dopamine withdrawal syndrome after surgery for Parkinsons disease: predictors and underlying mesolimbic denervation
001E89 (2009) Olivier Rascol [France] ; Santiago Perez-LloretRotigotine transdermal delivery for the treatment of Parkinson's disease.
002285 (2008) Rotigotine: Parkinson's disease: a step backward.
002487 (2008) D. Dupuy [France] ; J. P. Lesbre [France] ; P. Ger [France] ; M. Andrejak [France] ; O. Godefroy [France]Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications
002B00 (2006) Dominique Drapier [France] ; Sophie Drapier [France] ; Paul Sauleau [France] ; Pascal Derkinderen [France] ; Philippe Damier [France] ; Herve Allain [France] ; Marc Verin [France] ; Bruno Millet [France]Pathological gambling secondary to dopaminergic therapy in Parkinson's disease
002B77 (2005) Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
002B79 (2005) Isabelle Arnulf [France]Excessive daytime sleepiness in parkinsonism.
003053 (2003) N V Fedorova[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
003070 (2003) Olivier Rascol [France]Monoamine oxidase inhibitors--is it time to up the TEMPO?
003536 (2002) C. Lebrun-Frenay [France] ; M. Borg [France]Choosing the right dopamine agonist for patients with Parkinson's disease
003874 (2000) Pergolide and Parkinson's disease: new preparation. No clear benefit.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Agonists (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Agonists (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agonists (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024